Antiphospholipid Antibodies and Early Severe Preeclampsia.
Condition(s):Severe Preeclampsia; Antiphospholipid SyndromeLast Updated:January 5, 2015Unknown status
Hide Studies Not Open or Pending
Condition(s):Severe Preeclampsia; Antiphospholipid SyndromeLast Updated:January 5, 2015Unknown status
Condition(s):Fetal Growth Restriction; Antiphospholipid SyndromeLast Updated:January 5, 2015Unknown status
Condition(s):vitD3 Level in Cases of Recuurent Pregnancy LossLast Updated:October 31, 2017Unknown status
Condition(s):Pre-Eclampsia; Obesity; EndocrineLast Updated:January 8, 2019Completed
Condition(s):Gestational Diabetes MellitusLast Updated:May 3, 2018Completed
Condition(s):Maternal DeathLast Updated:May 19, 2023Recruiting
Condition(s):Dental Caries; Female InfertilityLast Updated:October 8, 2020Withdrawn
Condition(s):Pathophysiology of Placenta AccretaLast Updated:September 7, 2023Completed
Condition(s):Pre-EclampsiaLast Updated:October 24, 2017Unknown status
Condition(s):Threatened MiscarriageLast Updated:December 12, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.